ONCO Onconetix: Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

The market dynamics of the EV/EBITDA multiple, currently 0.00, allow for a valuation of Onconetix, Inc. (ONCO) through the lens of future sales of prostate therapy products. The business is based on the development of diagnostic tools for men's health. An innovative approach to treating hormonal imbalances helps the company avoid price wars with generic manufacturers, effectively protecting its profitability.

Onconetix Corp - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan ONCO (periode 23.11.2025 - 14.11.2026)

ONCO (onconetix.gcs-web.com): rincian analitis lan laporan miturut indikator

- rega saham lan target rega konsensus:

Kutipan saham Onconetix Corp|ONCO - Rata-rata rega prakiraan

- data kapitalisasi saham perusahaan:

Nilai pasar Onconetix Corporation|ONCO - Rega Tumbas Perusahaan

- indikator nilai buku ekuitas:

Nilai Buku saben Saham Onconetix|ONCO - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku onconetix.gcs-web.com|ONCO - Gunggung Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

Utang marang Ekuitas Onconetix, Inc.|ONCO - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Onconetix|ONCO - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Onconetix Corporation|ONCO - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Onconetix|Likuiditas cepet onconetix.gcs-web.com

- rincian asil keuangan lan kelipatan valuasi:

ONCO - Bathi perusahaan|Proyeksi bathi mangsa ngarep Onconetix, Inc.|ONCO - Kapitalisasi marang bathi|Prakiraan rega marang bathi Onconetix, Inc.|ONCO - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Onconetix Corporation|ONCO - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Onconetix|ONCO - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan onconetix.gcs-web.com|ONCO - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Onconetix, Inc.

- indikator volume dodolan lan pendapatan:

ONCO - Pendapatan reged perusahaan|Prakiraan pendapatan perusahaan Onconetix Corp|ONCO - Rasio kapitalisasi marang pendapatan|Multiplikator Forward P/S Onconetix Corporation

Pambiji fundamental perusahaan:Onconetix Corp ONCO

The EV/EBITDA multiple compares the total enterprise value of a business with its operating profit before depreciation, taxes, and interest, thereby determining the payback period for capital. For Onconetix, Inc. (ONCO), this calculation is critical, as future sales of targeted prostate cancer therapy will require significant investments in clinic infrastructure. By analyzing the EV/EBITDA trend of Onconetix, Inc. (ONCO), an investor can identify asset value inflection points prior to the drug's market launch.

Pesaing Onconetix, Inc. (ONCO)